268 related articles for article (PubMed ID: 37243163)
1. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
[TBL] [Abstract][Full Text] [Related]
2. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery.
Amaya M; Cheng H; Borisevich V; Navaratnarajah CK; Cattaneo R; Cooper L; Moore TW; Gaisina IN; Geisbert TW; Rong L; Broder CC
Antiviral Res; 2021 Sep; 193():105084. PubMed ID: 34077807
[TBL] [Abstract][Full Text] [Related]
3. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
4. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
5. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species.
Laing ED; Amaya M; Navaratnarajah CK; Feng YR; Cattaneo R; Wang LF; Broder CC
Virol J; 2018 Mar; 15(1):56. PubMed ID: 29587789
[TBL] [Abstract][Full Text] [Related]
6. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
7. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
8. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.
Khetawat D; Broder CC
Virol J; 2010 Nov; 7():312. PubMed ID: 21073718
[TBL] [Abstract][Full Text] [Related]
9. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein.
Kaku Y; Noguchi A; Marsh GA; McEachern JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
J Virol Methods; 2009 Sep; 160(1-2):7-13. PubMed ID: 19433112
[TBL] [Abstract][Full Text] [Related]
10. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
11. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
[TBL] [Abstract][Full Text] [Related]
12. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely Virus, from Fruit Bats in Madagascar.
Madera S; Kistler A; Ranaivoson HC; Ahyong V; Andrianiaina A; Andry S; Raharinosy V; Randriambolamanantsoa TH; Ravelomanantsoa NAF; Tato CM; DeRisi JL; Aguilar HC; Lacoste V; Dussart P; Heraud JM; Brook CE
J Virol; 2022 Sep; 96(18):e0092122. PubMed ID: 36040175
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
Zhu W; Smith G; Pickering B; Banadyga L; Yang M
Viruses; 2024 May; 16(5):. PubMed ID: 38793674
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
16. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.
Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS
J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743
[TBL] [Abstract][Full Text] [Related]
17. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
[TBL] [Abstract][Full Text] [Related]
18. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
19. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
20. Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays.
Yang M; Zhu W; Truong T; Pickering B; Babiuk S; Kobasa D; Banadyga L
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]